Delivery Order SPE2DR25D1104-SPE2DR26FK858
Award Date 1/6/26
Potential Completion Date 1/7/26
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,194.60 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used in the treatment...
- The Defense Logistics Agency awarded a $2,877.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a pharmaceutical delivery to be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, making this a...
- The Defense Logistics Agency awarded a delivery order valued at $8,134.43 to AmerisourceBergen Drug Corp for the supply of ACTEMRA 162 mg/0.9 mL syringes on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. ACTEMRA (tocilizumab) is a biologic immunosuppressant medication commonly used to treat...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,888.50 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Actemra (tocilizumab) is a biologic immunosuppressant medication used...
- The Defense Logistics Agency awarded a delivery order valued at $12,974.50 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The contract, executed on January 6, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is a non-set-aside procurement, indicating it was awarded through full and open competition. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Actemra 162 mg/0.9 ml syringes, with a ceiling value of $3,431.82 and a firm fixed price structure. This delivery order, which has an ultimate completion date of November 3, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used...
- The Defense Logistics Agency (DLA) awarded a $7,362.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 162 mg/0.9 mL Actemra syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfilled this delivery order under its...
- The Defense Logistics Agency awarded a delivery order valued at $39,386.96 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on November 28, 2025, with an ultimate completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,744.05 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 ml syringes on November 4, 2025, with completion expected by November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,303.85 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. This competitively awarded, firm fixed-price delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract involves no set-aside designation and represents a single-line pharmaceutical delivery under...